Published in Europace on July 04, 2013
The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study. PLoS One (2014) 0.77
Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI Scores. PLoS One (2016) 0.76
The CHA2DS2-VASc score as a predictor of high mortality in hospitalized heart failure patients. ESC Heart Fail (2016) 0.75
Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy. PLoS One (2017) 0.75
CHADS2 and modified CHA2DS2-VASc scores for the prediction of congestive heart failure in patients with nonvalvular atrial fibrillation. J Arrhythm (2017) 0.75
The Association between CHA2DS2-VASc Score and Mortality in Patients with Heart Failure with Reduced Ejection Fraction. Acta Cardiol Sin (2017) 0.75
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging (2013) 2.89
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol (2012) 2.37
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm (2010) 2.35
Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol (2006) 2.30
Real-time dynamic carbon dioxide administration: a novel treatment strategy for stabilization of periodic breathing with potential application to central sleep apnea. J Am Coll Cardiol (2010) 2.09
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol (2008) 2.07
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) (2015) 2.04
Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. Am J Emerg Med (2013) 2.02
[GISE/AIAC position paper on percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: recommendations for patient selection, facilities, competences, organizing and training requirements]. G Ital Cardiol (Rome) (2014) 1.98
Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol (2012) 1.95
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta (2008) 1.66
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem (2007) 1.66
Silent myocardial damage in cocaine addicts. Heart (2011) 1.65
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace (2011) 1.64
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) (2014) 1.61
Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J (2007) 1.60
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol (2005) 1.56
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med (2006) 1.51
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med (Hagerstown) (2014) 1.50
Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation (2005) 1.49
Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J Am Coll Cardiol (2006) 1.49
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Pacing Clin Electrophysiol (2008) 1.48
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur Heart J (2004) 1.46
Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol (2005) 1.42
[Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society]. G Ital Cardiol (Rome) (2010) 1.41
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. Int J Cardiol (2013) 1.40
Real-time 3-dimensional transthoracic echocardiography improves the diagnosis of isolated ventricular noncompaction. J Ultrasound Med (2007) 1.39
Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem (2003) 1.39
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? Intern Emerg Med (2013) 1.38
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol (2006) 1.28
The paradox of low BNP levels in obesity. Heart Fail Rev (2012) 1.23
A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace (2012) 1.22
Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation (2004) 1.19
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J Am Coll Cardiol (2009) 1.18
Implantation of a single chamber pacemaker in patients with triple mechanical valve prosthesis: utilization of coronary sinus distal branches to stimulate the left ventricle. Pacing Clin Electrophysiol (2002) 1.18
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 1.09
P wave assessment: state of the art update. Card Electrophysiol Rev (2002) 1.09
B-type natriuretic peptide assay for complex congenital heart diseases: clinical relevance versus methodological issues. J Am Coll Cardiol (2013) 1.08
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol (2008) 1.07
Amino terminal fragment of pro-B-type natriuretic peptide for complex congenital heart diseases: one for all, all for one? J Am Coll Cardiol (2014) 1.07
Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med (2004) 1.07
Incremental prognostic value of coronary CT angiography in patients with suspected coronary artery disease. Circ Cardiovasc Imaging (2010) 1.06
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci (Lond) (2008) 1.06
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res (2008) 1.05
Gamma-glutamyltransferase activity in human atherosclerotic plaques--biochemical similarities with the circulating enzyme. Atherosclerosis (2008) 1.03
Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol (2005) 1.03
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil (2010) 1.03
Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol (2006) 1.03
Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol (2011) 1.01
The need of a hybrid approach for the treatment of atrial fibrillation. Heart Surg Forum (2005) 1.00
Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope. Europace (2005) 1.00
Effects of right ventricular pacing on intra-left ventricular electromechanical activation in patients with native narrow QRS. Am J Cardiol (2006) 1.00
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. Liver Int (2011) 1.00
A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem (2007) 1.00
C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity. Eur J Heart Fail (2005) 0.99
The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med (2004) 0.98
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. Eur J Cardiovasc Prev Rehabil (2010) 0.97
Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. BMJ Open (2012) 0.96
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers (2009) 0.96
Fibrosis and mortality in patients with dilated cardiomyopathy. JAMA (2013) 0.96
Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol (2003) 0.94
Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study. Europace (2006) 0.94
S38G single-nucleotide polymorphism at the KCNE1 locus is associated with heart failure. Heart Rhythm (2009) 0.93
Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis (2005) 0.93
Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol (2012) 0.92
Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail (2006) 0.92
Rotational mechanics of the left ventricle in AL amyloidosis. Echocardiography (2010) 0.92
Rate-responsive pacing regulated by cardiac haemodynamics. Europace (2005) 0.91
Clinical profile of recurrent community-acquired pneumonia in children. BMC Pulm Med (2013) 0.91
Energy metabolism in the normal and in the diabetic heart. Curr Pharm Des (2009) 0.91
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. Eur J Heart Fail (2012) 0.90
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. Am J Cardiol (2007) 0.90
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. Circ Arrhythm Electrophysiol (2012) 0.90
Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications. Am Heart J (2008) 0.90
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. Peptides (2008) 0.90
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. Eur J Heart Fail (2005) 0.90